Brief: UK's MHRA Approves Zolbetuximab To Treat Adults With Stomach Or Gastro-Oesophageal Junction Cancer
14/08/2024 11:46
Aug 14 (Reuters) - UK's Medicines and Healthcare
products Regulatory Agency:
* UK'S MHRA: MHRA APPROVES ZOLBETUXIMAB TO TREAT ADULTS WITH
STOMACH OR GASTRO-OESOPHAGEAL JUNCTION CANCER
* UK'S MHRA: ZOLBETUXIMAB APPROVED TO TREAT ADULTS WITH
STOMACH OR
GASTRO-OESOPHAGEAL JUNCTION CANCER
Further company coverage: 4503.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn